Introduction:Basic information about CAS 127985-74-4|p-SCN-Bn-DOTA, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | p-SCN-Bn-DOTA |
|---|
| CAS Number | 127985-74-4 | Molecular Weight | 551.61 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C24H33N5O8S | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | 2-[4,7,10-tris(carboxymethyl)-6-[(4-isothiocyanatophenyl)methyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid |
|---|
| Synonym | More Synonyms |
|---|
p-SCN-Bn-DOTA BiologicalActivity
| Description | p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunotherapy of tumor[1][2]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Others >>Others |
|---|
| In Vitro | p-SCN-Bn-DOTA is complexed with 5 different metal ions: In(III), Y(III), Lu(III), Gd(III) and Cu(II)[2]. |
|---|
| References | [1]. Vera DRB, et, al. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors. Cancer Biother Radiopharm. 2011 Jun;26(3):287-97. [2]. Giannini G, et, al. Synthesis and preliminary in vitro evaluation of DOTA-Tenatumomab conjugates for theranostic applications in tenascin expressing tumors. Bioorg Med Chem. 2019 Aug 1;27(15):3248-3253. |
|---|
Chemical & Physical Properties
| Molecular Formula | C24H33N5O8S |
|---|
| Molecular Weight | 551.61 |
|---|
| Exact Mass | 551.20500 |
|---|
| PSA | 206.61000 |
|---|
| InChIKey | UDOPJKHABYSVIX-UHFFFAOYSA-N |
|---|
| SMILES | O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)C(Cc2ccc(N=C=S)cc2)CN(CC(=O)O)CC1 |
|---|
Synonyms
| UNII-13KT123BYW |
| 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| cDOTA-Bnz-NCS |
| p-isothiocyanatobenzyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid,2-((4-isothiocyanatophenyl)methyl) |
| 2-(p-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraaceticacid |
| p-SCN-Bz-DOTA |
| p-SCN-Bn-DOTA |
| 2-(p-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |